These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22552526)
1. Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells. Ruan J; Zhang L; Yan L; Liu Y; Yue Z; Chen L; Wang AY; Chen W; Zheng S; Wang S; Lu Y Mol Med Rep; 2012 Jul; 6(1):232-8. PubMed ID: 22552526 [TBL] [Abstract][Full Text] [Related]
2. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition. Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392 [TBL] [Abstract][Full Text] [Related]
3. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling. Putri HE; Sritularak B; Chanvorachote P Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
5. Nannocystin Ax, a natural elongation factor 1α inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells. Sun C; Liu R; Xia M; Hou Y; Wang X; Lu JJ; Liu B; Chen X Toxicol Appl Pharmacol; 2021 Jun; 420():115535. PubMed ID: 33848516 [TBL] [Abstract][Full Text] [Related]
6. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma. Yao WL; Ko BS; Liu TA; Liang SM; Liu CC; Lu YJ; Tzean SS; Shen TL; Liou JY Anticancer Agents Med Chem; 2014 Jan; 14(1):29-34. PubMed ID: 23855336 [TBL] [Abstract][Full Text] [Related]
7. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3. Petpiroon N; Sritularak B; Chanvorachote P BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478 [TBL] [Abstract][Full Text] [Related]
8. Dehydroeffusol inhibits hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway. Wei H; Zhang F; Wang J; Zhao M; Hou T; Li L Biosci Rep; 2020 May; 40(5):. PubMed ID: 32426814 [TBL] [Abstract][Full Text] [Related]
9. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells. Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787 [TBL] [Abstract][Full Text] [Related]
10. Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway. Chen KC; Chen CY; Lin CR; Yang TY; Chen TH; Wu LC; Wu CC Life Sci; 2013 Dec; 93(24):924-33. PubMed ID: 24140887 [TBL] [Abstract][Full Text] [Related]
11. Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling. Treesuwan S; Sritularak B; Chanvorachote P; Pongrakhananon V Sci Rep; 2018 May; 8(1):8009. PubMed ID: 29789636 [TBL] [Abstract][Full Text] [Related]
12. Mangiferin inhibits lipopolysaccharide-induced epithelial-mesenchymal transition (EMT) and enhances the expression of tumor suppressor gene PER1 in non-small cell lung cancer cells. Lin YS; Tsai KL; Chen JN; Wu CS Environ Toxicol; 2020 Oct; 35(10):1070-1081. PubMed ID: 32420661 [TBL] [Abstract][Full Text] [Related]
13. Ursolic Acid Attenuates TGF-β1-Induced Epithelial-Mesenchymal Transition in NSCLC by Targeting Integrin αVβ5/MMPs Signaling. Ruan JS; Zhou H; Yang L; Wang L; Jiang ZS; Sun H; Wang SM Oncol Res; 2019 May; 27(5):593-600. PubMed ID: 28911340 [TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Liu K; Guo L; Miao L; Bao W; Yang J; Li X; Xi T; Zhao W Anticancer Drugs; 2013 Jun; 24(5):494-503. PubMed ID: 23511428 [TBL] [Abstract][Full Text] [Related]
15. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158 [TBL] [Abstract][Full Text] [Related]
16. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Da C; Liu Y; Zhan Y; Liu K; Wang R Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176 [TBL] [Abstract][Full Text] [Related]
17. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression. Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422 [TBL] [Abstract][Full Text] [Related]
18. Cinnamomum cassia extracts reverses TGF-β1-induced epithelial-mesenchymal transition in human lung adenocarcinoma cells and suppresses tumor growth in vivo. Lin CY; Hsieh YH; Yang SF; Chu SC; Chen PN; Hsieh YS Environ Toxicol; 2017 Jul; 32(7):1878-1887. PubMed ID: 28258635 [TBL] [Abstract][Full Text] [Related]
19. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance. Ko H Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124 [TBL] [Abstract][Full Text] [Related]
20. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway. Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]